Healthcare -
Biotechnology - NASDAQ - US
$ 6.57
-16.1 %
$ 37.8 M
Market Cap
-0.26
P/E
ATRA - SHORT-TERM DEBT
Short-term Debt ATRA - Atara Biotherapeutics, Inc.
12.2 M
LAST VALUE
110.33%
2 YEAR CAGR
83.40%
5 YEAR CAGR
0.00%
10 YEAR CAGR